Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · H2 FY26

Global Longlife Hospital and Research H2 FY26 Results: Net Loss of ₹0.4 Cr, Loss Narrows

Global Longlife Hospital and Research Ltd reported a net loss of ₹0.4 Cr for H2 FY26.

H2 FY26 at a glance · ₹ crore
MetricH2 FY26H1 FY26H2 FY25
Revenue from operations0.00.00.0
Other income0.00.0-0.7
Total income0.00.0-0.7
Profit before exceptional items & tax-0.4-0.6-1.0
Profit before tax-0.4-0.6-1.0
Net profit-0.4-1.3-1.0
Operating margin0.0%0.0%142.9%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Source

BSE results filing, BSE: 543520. Figures extracted from the filing.

Read the filing ↗

Global Longlife Hospital and Research Ltd: key numbers

Share price
₹14.00
Market cap
₹14.70 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-1.72 Cr
P/E (TTM)
-8.6×Sector 37.2×
Promoter holding
22.88%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Global Longlife Hospital and Research Ltd

All →
12:21 IST BSE
Capital Structure Change

Global Longlife Hospital and Research Capital Structure Change

Abhishek Ashvinbhai Kamdar HUF acquired 5,35,000 shares of Global Longlife Hospital and Research Ltd via the open market. This constitutes a non-promoter stake acquisition.